Thieme E-Books & E-Journals -
Back
Thromb Haemost 2008; 100(04): 648-654
DOI: 10.1160/TH08-03-0190
Cardiovascular Biology and Cell Signalling
Schattauer GmbH

Tirofiban optimizes platelet inhibition for immediate percutaneous coronary intervention in high-risk acute coronary syndromes

Boris T. Ivandic*
1   Department of Medicine III, University of Heidelberg, Heidelberg, Germany
,
Kerstin Kurz*
1   Department of Medicine III, University of Heidelberg, Heidelberg, Germany
,
Frieder Keck
1   Department of Medicine III, University of Heidelberg, Heidelberg, Germany
,
Peter Staritz
1   Department of Medicine III, University of Heidelberg, Heidelberg, Germany
,
Stephanie Lehrke
1   Department of Medicine III, University of Heidelberg, Heidelberg, Germany
,
Hugo A. Katus
1   Department of Medicine III, University of Heidelberg, Heidelberg, Germany
,
Evangelos Giannitsis
1   Department of Medicine III, University of Heidelberg, Heidelberg, Germany
› Author Affiliations